TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Amber BioSciences AB
Closing information (x1000 DKK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
81
|
90
|
87 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
20
|
39
|
32 |
EBITDA |
20
|
39
|
32 |
Total assets |
803
|
816
|
893 |
Current assets |
214
|
195
|
223 |
Current liabilities |
0
|
14
|
51 |
Equity capital |
231
|
222
|
0 |
- share capital |
63
|
66
|
0 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
28.8%
|
27.2%
|
0% |
Turnover per employee |
81
|
90
|
87 |
Profit as a percentage of turnover |
24.7%
|
43.3%
|
36.8% |
Return on assets (ROA) |
2.5%
|
4.8%
|
3.6% |
Current ratio |
1392.9%
|
437.3% | |
Return on equity (ROE) |
8.7%
|
17.6% | |
Change turnover |
-6
|
11
![]() |
11 |
Change turnover % |
-7%
|
13%
|
14% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.